CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 884546
SAN FRANCISCO, CA
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,013,966,007
+$156,220,271 QoQ
Shares Held
2,041,282
+6.3% QoQ
Ownership
0.805%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#25
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. VRTX ranks #1 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,013,966,007 | 2,041,282 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $857,745,736 | 1,920,871 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $842,896,432 | 1,859,221 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $716,674,176 | 1,829,931 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $789,617,850 | 1,773,625 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $836,450,734 | 1,725,281 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $670,031,992 | 1,663,849 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $756,381,462 | 1,626,347 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $752,757,757 | 1,605,986 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $650,679,382 | 1,556,612 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $614,080,829 | 1,509,206 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $510,283,412 | 1,467,428 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $510,221,640 | 1,449,864 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $454,689,174 | 1,443,137 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $408,920,565 | 1,416,028 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $401,864,147 | 1,387,940 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $384,387,484 | 1,364,092 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $346,428,802 | 1,327,466 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $277,066,684 | 1,261,688 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $225,283,659 | 1,241,985 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $245,270,595 | 1,216,439 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $259,248,668 | 1,206,425 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $297,924,768 | 1,260,577 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $352,296,892 | 1,294,638 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $358,794,129 | 1,235,900 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $277,334,056 | 1,165,514 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||